Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,409 | 47,161 | 50,501 | 42,350 | 39,977 |
| Marketable Securities | 5 | 5 | 15 | 11 | 22 |
| Receivables | 1,358 | 1,924 | 926 | 10,132 | 135 |
| Other current assets | 948 | 1,194 | 1,407 | 1,211 | 2,595 |
| TOTAL | $44,834 | $51,844 | $53,948 | $54,188 | $43,461 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 3 | 4 |
| TOTAL | $N/A | $N/A | $N/A | $3 | $4 |
| Total Assets | $44,834 | $51,844 | $53,948 | $54,191 | $43,465 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 634 | 2,064 | 2,153 | 1,890 | 2,323 |
| Accrued Expenses | 3,490 | 3,649 | 1,815 | 1,926 | 3,438 |
| Other current liabilities | 74 | 74 | 74 | 93 | N/A |
| TOTAL | $4,198 | $5,787 | $4,042 | $3,909 | $5,761 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,198 | $5,787 | $4,042 | $3,909 | $5,761 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,198 | 25,924 | 24,813 | 22,638 | 21,008 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -96,337 | -88,572 | -81,466 | -76,671 | -82,232 |
| TOTAL | $40,636 | $46,057 | $49,906 | $50,282 | $37,704 |
| Total Liabilities And Equity | $44,834 | $51,844 | $53,948 | $54,191 | $43,465 |